BSX Boston Scientific Corporation

This $9.5M insider cluster—anchored by the CEO’s $9M—reinforces the existing buy thesis that the post-selloff price undervalues the franchise, as it mirrors the conviction seen in the prior cluster from early August.

A weekly close below the cluster’s lowest fill price, especially if accompanied by a negative MACD cross, would call the insiders’ timing into question and weaken the signal.